# Treating Contact Lens Discomfort With Varenicline Solution Nasal Spray 0.03mg

> **NCT07705893** · NA · RECRUITING · sponsor: **Ocular Aesthetics, LLC dba Ocular Clinical Trials** · enrollment: 50 (estimated)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** Tyrvaya

## Key facts

- **NCT ID:** NCT07705893
- **Lead sponsor:** Ocular Aesthetics, LLC dba Ocular Clinical Trials
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-28
- **Primary completion:** 2026-12
- **Final completion:** 2027-03
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07705893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07705893, "Treating Contact Lens Discomfort With Varenicline Solution Nasal Spray 0.03mg". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07705893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*